285 related articles for article (PubMed ID: 12962147)
21. Down-regulation of NDRG1 promotes migration of cancer cells during reoxygenation.
Lai LC; Su YY; Chen KC; Tsai MH; Sher YP; Lu TP; Lee CY; Chuang EY
PLoS One; 2011; 6(8):e24375. PubMed ID: 21912630
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of Xenopus NDRG1.
Kyuno J; Fukui A; Michiue T; Asashima M
Biochem Biophys Res Commun; 2003 Sep; 309(1):52-7. PubMed ID: 12943662
[TBL] [Abstract][Full Text] [Related]
23. The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1.
Liu W; Yue F; Zheng M; Merlot A; Bae DH; Huang M; Lane D; Jansson P; Lui GY; Richardson V; Sahni S; Kalinowski D; Kovacevic Z; Richardson DR
Oncotarget; 2015 Apr; 6(11):8851-74. PubMed ID: 25860930
[TBL] [Abstract][Full Text] [Related]
24. Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome.
Kim DK; Alvarado CS; Abramowsky CR; Gu L; Zhou M; Soe MM; Sullivan K; George B; Schemankewitz E; Findley HW
Pediatr Dev Pathol; 2005; 8(6):621-9. PubMed ID: 16328668
[TBL] [Abstract][Full Text] [Related]
25. Human neuroblastoma cell lines that express N-myc without gene amplification.
Wada RK; Seeger RC; Brodeur GM; Einhorn PA; Rayner SA; Tomayko MM; Reynolds CP
Cancer; 1993 Dec; 72(11):3346-54. PubMed ID: 8242562
[TBL] [Abstract][Full Text] [Related]
26. Involvement of Myc targets in c-myc and N-myc induced human tumors.
Ben-Yosef T; Yanuka O; Halle D; Benvenisty N
Oncogene; 1998 Jul; 17(2):165-71. PubMed ID: 9674700
[TBL] [Abstract][Full Text] [Related]
27. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells.
Lutz W; Schwab M
Oncogene; 1997 Jul; 15(3):303-15. PubMed ID: 9233765
[TBL] [Abstract][Full Text] [Related]
28. FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma.
Li D; Mei H; Qi M; Yang D; Zhao X; Xiang X; Pu J; Huang K; Zheng L; Tong Q
Oncotarget; 2013 Nov; 4(11):2021-44. PubMed ID: 24269992
[TBL] [Abstract][Full Text] [Related]
29. N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma.
Kang J; Rychahou PG; Ishola TA; Mourot JM; Evers BM; Chung DH
Oncogene; 2008 Jun; 27(28):3999-4007. PubMed ID: 18278068
[TBL] [Abstract][Full Text] [Related]
30. N-myc modulates expression of p73 in neuroblastoma.
Zhu X; Wimmer K; Kuick R; Lamb BJ; Motyka S; Jasty R; Castle VP; Hanash SM
Neoplasia; 2002; 4(5):432-9. PubMed ID: 12192602
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of cathepsin proteases attenuates migration and sensitizes aggressive N-Myc amplified human neuroblastoma cells to doxorubicin.
Gangoda L; Keerthikumar S; Fonseka P; Edgington LE; Ang CS; Ozcitti C; Bogyo M; Parker BS; Mathivanan S
Oncotarget; 2015 May; 6(13):11175-90. PubMed ID: 25883214
[TBL] [Abstract][Full Text] [Related]
32. c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571.
Vitali R; Cesi V; Nicotra MR; McDowell HP; Donfrancesco A; Mannarino O; Natali PG; Raschellà G; Dominici C
Int J Cancer; 2003 Aug; 106(2):147-52. PubMed ID: 12800187
[TBL] [Abstract][Full Text] [Related]
33. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.
Raschella G; Romeo A; Negroni A; Pucci S; Dominici C; Castello MA; Bevilacqua P; Felsani A; Calabretta B
Cancer Res; 1994 Apr; 54(8):2251-5. PubMed ID: 8174135
[TBL] [Abstract][Full Text] [Related]
34. Expression and DNA-binding activity of MYCN/Max and Mnt/Max during induced differentiation of human neuroblastoma cells.
Smith AG; Popov N; Imreh M; Axelson H; Henriksson M
J Cell Biochem; 2004 Aug; 92(6):1282-95. PubMed ID: 15258910
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN
Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835
[TBL] [Abstract][Full Text] [Related]
36. Next-generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN-amplified neuroblastoma.
Schramm A; Köster J; Marschall T; Martin M; Schwermer M; Fielitz K; Büchel G; Barann M; Esser D; Rosenstiel P; Rahmann S; Eggert A; Schulte JH
Int J Cancer; 2013 Feb; 132(3):E106-15. PubMed ID: 22907398
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma.
Chua MS; Sun H; Cheung ST; Mason V; Higgins J; Ross DT; Fan ST; So S
Mod Pathol; 2007 Jan; 20(1):76-83. PubMed ID: 17170744
[TBL] [Abstract][Full Text] [Related]
38. ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.
Wang Q; Hii G; Shusterman S; Mosse Y; Winter CL; Guo C; Zhao H; Rappaport E; Hogarty MD; Maris JM
Cancer Res; 2003 Apr; 63(7):1631-5. PubMed ID: 12670915
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of N-myc downstream regulated gene 1 caused by the methylation of CpG islands of NDRG1 promoter promotes proliferation and invasion of prostate cancer cells.
Li Y; Pan P; Qiao P; Liu R
Int J Oncol; 2015 Sep; 47(3):1001-8. PubMed ID: 26202882
[TBL] [Abstract][Full Text] [Related]
40. CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression.
Zhao X; Li D; Pu J; Mei H; Yang D; Xiang X; Qu H; Huang K; Zheng L; Tong Q
Oncogene; 2016 Jul; 35(27):3565-76. PubMed ID: 26549029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
